Position in AMGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$260,722,960
-$42,050,244 QoQ
Shares Held
741,006
-19.9% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $4,969,350,861 across 12 Drug Manufacturers - General names. AMGN ranks #8 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,624,427 | $1,503,689,491 | |
| 2 | LLY |
ELI LILLY & Co
|
1,157,476 | $1,064,611,698 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,423,414 | $616,491,207 | |
| 4 | JNJ |
Johnson & Johnson
|
1,642,509 | $401,494,898 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491,841 | $324,460,498 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,316,095 | $278,603,066 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,407,916 | $267,340,104 | |
| 8 | AMGN |
Amgen Inc
This page
|
741,006 | $260,722,960 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $260,722,960 | 741,006 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $302,773,204 | 925,035 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $54,381,633 | 192,706 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $43,914,986 | 157,283 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $103,515,291 | 332,259 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $40,480,519 | 155,312 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $262,984,902 | 816,191 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $179,650,001 | 574,972 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $106,749,934 | 375,457 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $155,908,106 | 541,310 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $149,775,110 | 557,282 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $113,265,057 | 510,157 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $134,097,516 | 554,695 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $161,032,462 | 613,130 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $134,052,592 | 594,732 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $140,357,579 | 576,891 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $115,959,944 | 479,530 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $56,049,250 | 249,141 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $73,588,382 | 346,054 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $90,438,318 | 371,029 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $93,485,878 | 375,732 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $93,908,754 | 408,441 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $95,756,558 | 376,757 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $81,913,706 | 347,298 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $72,131,333 | 355,800 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||